Edward E. Soltis

1.4k total citations
38 papers, 1.2k citations indexed

About

Edward E. Soltis is a scholar working on Physiology, Molecular Biology and Biochemistry. According to data from OpenAlex, Edward E. Soltis has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 16 papers in Molecular Biology and 10 papers in Biochemistry. Recurrent topics in Edward E. Soltis's work include Nitric Oxide and Endothelin Effects (16 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Receptor Mechanisms and Signaling (9 papers). Edward E. Soltis is often cited by papers focused on Nitric Oxide and Endothelin Effects (16 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Receptor Mechanisms and Signaling (9 papers). Edward E. Soltis collaborates with scholars based in United States, India and Nigeria. Edward E. Soltis's co-authors include Lisa A. Cassis, Dianne M. Perez, Michael T. Piascik, F P Field, M T Piascik, Mackenzie Smith, Richard D. Guarino, D L Saussy, Marta S. Smith and Michael J. Katovich and has published in prestigious journals such as Circulation Research, Endocrinology and Journal of Controlled Release.

In The Last Decade

Edward E. Soltis

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward E. Soltis United States 17 528 493 485 249 202 38 1.2k
Ian N. Bratz United States 22 448 0.8× 670 1.4× 415 0.9× 197 0.8× 133 0.7× 36 1.3k
Mala T. Kailasam United States 15 225 0.4× 368 0.7× 367 0.8× 121 0.5× 116 0.6× 22 1.1k
Nobushige Yamashita Japan 24 444 0.8× 689 1.4× 650 1.3× 202 0.8× 91 0.5× 39 2.2k
F Kristek Slovakia 22 594 1.1× 409 0.8× 239 0.5× 149 0.6× 109 0.5× 68 1.3k
Hamao Ijichi Japan 17 188 0.4× 348 0.7× 329 0.7× 153 0.6× 129 0.6× 115 1.1k
Kumi Nakamura Japan 22 330 0.6× 191 0.4× 286 0.6× 183 0.7× 141 0.7× 64 1.0k
Tomohiko Ishikawa Japan 13 313 0.6× 255 0.5× 495 1.0× 100 0.4× 223 1.1× 14 1.2k
Hiromitsu Matsui Japan 16 199 0.4× 277 0.6× 292 0.6× 159 0.6× 151 0.7× 21 1.0k
Uffe Bang Olsen Denmark 18 260 0.5× 173 0.4× 526 1.1× 120 0.5× 447 2.2× 50 1.4k
Asli F. Ceylan‐Isik United States 19 317 0.6× 499 1.0× 517 1.1× 196 0.8× 79 0.4× 25 1.5k

Countries citing papers authored by Edward E. Soltis

Since Specialization
Citations

This map shows the geographic impact of Edward E. Soltis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward E. Soltis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward E. Soltis more than expected).

Fields of papers citing papers by Edward E. Soltis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward E. Soltis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward E. Soltis. The network helps show where Edward E. Soltis may publish in the future.

Co-authorship network of co-authors of Edward E. Soltis

This figure shows the co-authorship network connecting the top 25 collaborators of Edward E. Soltis. A scholar is included among the top collaborators of Edward E. Soltis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward E. Soltis. Edward E. Soltis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lipke, David W., et al.. (1997). Multiple Polyamine Regulatory Pathways Control Compensatory Cardiovascular Hypertrophy in Coarctation Hypertension. Clinical and Experimental Hypertension. 19(3). 269–295. 8 indexed citations
2.
Lipke, David W., et al.. (1997). Eflornithine Alters Changes in Vascular Responsiveness Associated with Coarctation Hypertension. Clinical and Experimental Hypertension. 19(3). 297–312. 1 indexed citations
3.
Peuler, Jacob D., et al.. (1997). Disparate effects of antidiabetic drugs on arterial contraction. Metabolism. 46(10). 1199–1205. 25 indexed citations
4.
Piascik, Michael T., et al.. (1996). α-Adrenoceptors and vascular regulation: Molecular, pharmacologic and clinical correlates. Pharmacology & Therapeutics. 72(3). 215–241. 84 indexed citations
5.
Lipke, David W., et al.. (1996). RGD-containing peptides induce endothelium-dependent and independent vasorelaxations of rat aortic rings. Regulatory Peptides. 63(1). 23–29. 18 indexed citations
6.
Çalış, Ünsal, et al.. (1994). Synthesis of Novel Aminopropylguanidine Derivatives with Potential Antihypertensive Activity. Pharmaceutical Research. 11(8). 1211–1215. 1 indexed citations
7.
Soltis, Edward E., et al.. (1994). Eflornithine Treatment in SHR: Potential Role of Vascular Polyamines and Ornithine Decarboxylase in Hypertension. Clinical and Experimental Hypertension. 16(5). 595–610. 7 indexed citations
8.
Piascik, Michael T., Marta S. Smith, Edward E. Soltis, & Dianne M. Perez. (1994). Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle.. Molecular Pharmacology. 46(1). 30–40. 84 indexed citations
9.
Soltis, Edward E., et al.. (1993). Acute and Chronic Effects of Losartan (Dup 753) on Blood Pressure and Vascular Reactivity in Normotensive Rats. Clinical and Experimental Hypertension. 15(1). 171–184. 27 indexed citations
10.
11.
Piascik, M T, Mackenzie Smith, Kirk W. Barron, & Edward E. Soltis. (1993). The regulation of regional hemodynamics by alpha-1 adrenoceptor subtypes in the conscious rat.. Journal of Pharmacology and Experimental Therapeutics. 267(3). 1250–1255. 12 indexed citations
12.
Soltis, Edward E., et al.. (1993). Chronic Hypertension andVascular Alterations followingShort-Term High Dietary SaltIntake in Postweaning Rats. Developmental Pharmacology and Therapeutics. 20(1-2). 107–110. 7 indexed citations
13.
Cassis, Lisa A., et al.. (1992). Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 262(3). 1168–1172. 36 indexed citations
14.
Soltis, Edward E., et al.. (1992). Ontogeny of Vascular SmoothMuscle Responsiveness in thePostweaning Rat. Developmental Pharmacology and Therapeutics. 18(1-2). 44–54. 7 indexed citations
15.
Piascik, Michael T., et al.. (1991). Evidence for a complex interaction between the subtypes of the α1-adrenoceptor. European Journal of Pharmacology. 199(3). 279–289. 43 indexed citations
16.
Soltis, Edward E. & Lisa A. Cassis. (1991). Influence of Perivascular Adipose Tissue on Rat Aortic Smooth Muscle Responsiveness. Clinical and Experimental Hypertension Part A Theory and Practice. 13(2). 277–296. 302 indexed citations
17.
Soltis, Edward E., et al.. (1991). Age-Dependent Salt-Induced Hypertension in the Rat: Prevention with DSP-4, A Selective Noradrenergic Neurotoxin. Clinical and Experimental Hypertension Part A Theory and Practice. 13(4). 557–572. 2 indexed citations
18.
Soltis, Edward E. & Michael J. Katovich. (1991). Reduction in Aortic Smooth Muscle Beta-Adrenergic Responsiveness Results in Enhanced Norepinephrine Responsiveness in the Dahl Salt-Sensitive Rat. Clinical and Experimental Hypertension Part A Theory and Practice. 13(1). 117–132. 10 indexed citations
19.
Katovich, Michael J., et al.. (1985). Role of Peripheral Adrenergic Responsiveness in the Development of DOCA/NaCl Hypertension in Rats. Pharmaceutical Research. 2(6). 298–301. 1 indexed citations
20.
Katovich, Michael J., Edward E. Soltis, & F P Field. (1984). Effects of NaCl on vascular responsiveness in male rats. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 78(2). 369–372. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026